phentermine has been researched along with Delayed Effects, Prenatal Exposure in 2 studies
Phentermine: A central nervous system stimulant and sympathomimetic with actions and uses similar to those of DEXTROAMPHETAMINE. It has been used most frequently in the treatment of obesity.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Food and Drug Administration approved phentermine-topiramate for obesity in 2012 and required a Risk Evaluation and Mitigation Strategy (REMS) to prevent prenatal exposure." | 8.31 | Assessment of the Risk Evaluation and Mitigation Strategy (REMS) for Phentermine-Topiramate to Prevent Exposure During Pregnancy. ( Brown, JD; Donahoo, WT; Hampp, C; Sarayani, A; Winterstein, AG, 2023) |
| " Food and Drug Administration approved phentermine-topiramate for obesity in 2012 and required a Risk Evaluation and Mitigation Strategy (REMS) to prevent prenatal exposure." | 4.31 | Assessment of the Risk Evaluation and Mitigation Strategy (REMS) for Phentermine-Topiramate to Prevent Exposure During Pregnancy. ( Brown, JD; Donahoo, WT; Hampp, C; Sarayani, A; Winterstein, AG, 2023) |
| "Pregnant rats were treated on Days 16-20 of pregnancy with 30 mg/kg chlorphentermine hydrochloride (CP) or an equal volume of 0." | 3.66 | Chlorphentermine-induced neonatal and maternal pulmonary phospholipidosis in rats. ( Reasor, MJ; Thoma-Laurie, DL; Walker, ER, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sarayani, A | 1 |
| Donahoo, WT | 1 |
| Hampp, C | 1 |
| Brown, JD | 1 |
| Winterstein, AG | 1 |
| Thoma-Laurie, DL | 1 |
| Walker, ER | 1 |
| Reasor, MJ | 1 |
2 other studies available for phentermine and Delayed Effects, Prenatal Exposure
| Article | Year |
|---|---|
Assessment of the Risk Evaluation and Mitigation Strategy (REMS) for Phentermine-Topiramate to Prevent Exposure During Pregnancy.
Topics: Anti-Obesity Agents; Contraceptive Agents; Female; Fructose; Humans; Obesity; Phentermine; Pregnancy | 2023 |
Chlorphentermine-induced neonatal and maternal pulmonary phospholipidosis in rats.
Topics: Animals; Chlorphentermine; Female; Lung; Macrophages; Microscopy, Electron; Phentermine; Phospholipi | 1983 |